Fate Therapeutics Inc (FATE)

[NY1972]

another frontier, inflammatory diseases

CD19 CAR-T coming to IBD $CABA $KYTX $CGEM

New N=1 case report from Schett describes clinical / biochemical remission achieved with auto CD19 CAr-T in refractory Ulcerative Colitis

Can't find the article anywhere... potentially a bungled embargo? Should be on NEJM soon enough pic.twitter.com/I1ckADrduu

— Professor Oak (@Prof_Oak_) September 23, 2025